Detalles de la búsqueda
1.
Ten-year patterns in blood product utilization during cardiothoracic surgery with cardiopulmonary bypass in a tertiary hospital.
Transfusion
; 54(10 Pt 2): 2608-16, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24372139
2.
Intraoperative cell salvage is associated with reduced postoperative blood loss and transfusion requirements in cardiac surgery: a cohort study.
Transfusion
; 53(11): 2782-9, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23445352
3.
The impact of balanced hydroxylethyl starch cardiopulmonary bypass priming solution on the fibrin part of clot formation: ex vivo rotation thromboelastometry.
Perfusion
; 26(3): 175-80, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21177722
4.
Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry.
J Cardiothorac Vasc Anesth
; 24(3): 422-6, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20056447
5.
Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
Thromb Haemost
; 116(2): 251-61, 2016 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27277211
6.
Residual blood processing by centrifugation, cell salvage or ultrafiltration in cardiac surgery: effects on clinical hemostatic and ex-vivo rheological parameters.
Blood Coagul Fibrinolysis
; 23(7): 622-8, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22828598
7.
Removal of aprotinin from low-dose aprotinin/tranexamic acid antifibrinolytic therapy increases transfusion requirements in cardiothoracic surgery.
Interact Cardiovasc Thorac Surg
; 12(2): 135-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21075830
Resultados
1 -
7
de 7
1
Próxima >
>>